Recruiting
Phase 1

Hyperbaric Oxygen

Sponsor:

Paul G. Harch, M.D.

Code:

NCT02105194

Conditions

Cerebral Decompression Illness, All Phases

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Interventions

Hyperbaric oxygen therapy

Study Details

Brief summary:

Chart review of patients who received hyperbaric oxygen therapy for cerebral decompression illness who also underwent SPECT brain blood flow imaging to see if SPECT brain imaging tracks and is consistent with the clinical condition of the patients.

Conditions

Cerebral Decompression Illness, All Phases

Study ID

NCT02105194

Start date

Jan, 2007

Status verified date

Apr, 2017

Completion date

Dec, 2018

Anticipated

Primary completion date

Dec, 2017

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • All patients in the P.I.'s practice who underwent hyperbaric oxygen therapy for cerebral decompression illness in the previous two decades who also underwent SPECT brain blood flow imaging early in the course of treatment and following completion of hyperbaric oxygen therapy.

Exclusion Criteria:

  • none

Study Design

Enrollment

45 participants

Anticipated

Intervention Model

Single group

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Hyperbaric oxygen therapy

Hyperbaric oxygen therapy

Interventions

Hyperbaric oxygen therapy

total body exposure to greater than atmospheric pressure oxygen

Primary outcome measure

  • SPECT brain imaging [ Time Frame: Within one month after completion of hyperbaric oxygen therapy ]

Central Contacts and Locations

Central contacts

Locations

Family Physicians Center

Recruiting

Marrero, Louisiana, United States, 70072

Contacts

Principal Investigator:

Paul G Harch, M.D.

More Information

Sponsor

Paul G. Harch, M.D.

Last update posted

Apr 18, 2017

Last verified

Apr, 2017

Keywords

  • cerebral decompression illness

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Paul G. Harch, M.D. on 2017-04-18.